Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Categories

All Quarterly Result Economy Mutual Fund Business Company Market Budget IPO

USFDA conducts inspection at Piramal Pharma's Bethlehem facility

Sep 29, 2023

By: BlinkX Research Team

Piramal Pharma Limited informed to the exchanges that the USFDA conducted a Good Manufacturing Practices (GMP) Inspection of company's Bethlehem facility from September 18, 2023 to September 27, 2023.

In a regulatory filing, the company mention that on conclusion of the inspection, a Form-483 was issued with 2 observations. Both observations relate to system improvement only, and none are related to data integrity.

Further, the Company is preparing a detailed response to said observations, which will be submitted to the US FDA within stipulated timelines.

“The Company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all observations”, Piramal Pharma said in a statement.